Kineziklinika - Company finances
|
EUR
|
2023
From: 2023-02-20
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 15,674 | 69,492 | 112,024 |
| Profit before tax | -5,173 | 12,257 | 13,409 |
| Net profit | -5,173 | 11,908 | 12,616 |
| Equity | -2,673 | 9,584 | 21,851 |
| Liabilities | 15,968 | 23,215 | 30,388 |
| Non-current assets | 3,190 | 4,026 | 38,401 |
| Current assets | 10,105 | 28,773 | 20,090 |
| Total assets | 13,295 | 32,799 | 58,491 |
|
Taxes paid
|
|||
| STI taxes | 659 | 2,177 | 13,222 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +343.4% | +61.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -38.9% | 36.3% | 21.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 124.2% | 57.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -33.0% | 17.1% | 11.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -33.0% | 17.6% | 12.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 2.4 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 11,495 | 37,905 | 37,341 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kineziklinika - Social security debts
The company had no debts to Sodra
Kineziklinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-28 | 2026-03-02 | 2.0 |
| 2025-10-26 | 2025-10-26 | 0.75 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kineziklinika, UAB (Private Limited Liability Company, code 306250686) provides physiotherapy activities. In the latest financial year 2025, the company generated revenue of €112.0K, up 61.2% year on year and 614.7% over two years. Net profit reached €12.6K, slightly above the €11.9K earned in 2024, while the profit margin eased to 11.3% from 17.1% a year earlier as the revenue base expanded. The 2023 result was a loss of €5.2K on revenue of €15.7K, showing a clear turnaround in 2024 and continued profitability in 2025. Balance sheet size increased to €58.5K in 2025 from €32.8K in 2024 and €13.3K in 2023. Equity strengthened to €21.9K, while liabilities rose to €30.4K. Long-term assets increased significantly to €38.4K, compared with €4.0K in 2024. Key indicators for 2025 show return on equity of 57.7%, return on assets of 21.6%, debt-to-equity of 1.39, and asset turnover of 1.92x. Revenue per employee was €37.3K.